Jim Simons Immunity Bio, Inc. Transaction History

Renaissance Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$2.68 - $6.14 $1.08 Million - $2.47 Million	401,681 New	401,681 $1.49 Million
Q1 2022 May 13, 2022	SELL	$5.05 - $7.53 $1.54 Million - $2.3 Million	-304,900 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$5.67 - $10.18 $549,893 - $987,286	96,983 Added 46.65%	304,900 $1.85 Million
Q3 2021 Nov 12, 2021	BUY	$9.17 - $14.24 $1.91 Million - $2.96 Million	207,917 New	207,917 $2.03 Million

202

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.